Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Kootstra NA"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 42
Tytuł:
SARS-CoV-2 suppresses TLR4-induced immunity by dendritic cells via C-type lectin receptor DC-SIGN.
Autorzy:
van der Donk LEH; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Bermejo-Jambrina M; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
van Hamme JL; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Volkers MMW; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
van Nuenen AC; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Kootstra NA; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Geijtenbeek TBH; Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2023 Oct 16; Vol. 19 (10), pp. e1011735. Date of Electronic Publication: 2023 Oct 16 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Superinfection*
COVID-19*/metabolism
Humans ; SARS-CoV-2/metabolism ; Toll-Like Receptor 4/metabolism ; Lipopolysaccharides/pharmacology ; Lipopolysaccharides/metabolism ; Lectins, C-Type/metabolism ; Cytokines/metabolism ; Dendritic Cells
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of a Novel HBV Encoded miRNA Using Next Generation Sequencing.
Autorzy:
Loukachov V; Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, 1105 AZ Amsterdam, The Netherlands.
van Dort KA; Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, 1105 AZ Amsterdam, The Netherlands.
Jansen L; Department of Gastroenterology and Hepatology, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Reesink HW; Department of Gastroenterology and Hepatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Kootstra NA; Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, 1105 AZ Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Jun 05; Vol. 14 (6). Date of Electronic Publication: 2022 Jun 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B, Chronic*
MicroRNAs*
Antiviral Agents/therapeutic use ; Hepatitis B virus/genetics ; High-Throughput Nucleotide Sequencing ; Humans ; Interferons/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nef Obtained from Individuals with HIV-1 Vary in Their Ability to Antagonize SERINC3- and SERINC5-Mediated HIV-1 Restriction.
Autorzy:
Kruize Z; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
van Nuenen AC; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
van Wijk SW; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Girigorie AF; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
van Dort KA; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Booiman T; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Kootstra NA; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Mar 06; Vol. 13 (3). Date of Electronic Publication: 2021 Mar 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*/genetics
HIV-1*/immunology
HIV Infections/*virology
Membrane Glycoproteins/*immunology
Membrane Proteins/*immunology
nef Gene Products, Human Immunodeficiency Virus/*genetics
Cohort Studies ; Host Microbial Interactions ; Humans ; Male ; Mutation ; Netherlands ; Sexual and Gender Minorities
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
Autorzy:
Larsen MD; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
de Graaf EL; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Sonneveld ME; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Plomp HR; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
Nouta J; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
Hoepel W; Department of Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Chen HJ; Department of Medical Biochemistry, Experimental Vascular Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.; Department of Cardiovascular Sciences, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.
Linty F; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Visser R; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Brinkhaus M; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Šuštić T; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
de Taeye SW; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Bentlage AEH; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Toivonen S; Finnish Red Cross Blood Service, Helsinki, Finland.
Koeleman CAM; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
Sainio S; Finnish Red Cross Blood Service, Helsinki, Finland.
Kootstra NA; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.
Brouwer PJM; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.
Geyer CE; Department of Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Derksen NIL; Department of Immunopathology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Wolbink G; Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.
de Winther M; Department of Medical Biochemistry, Experimental Vascular Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.; Department of Cardiovascular Sciences, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.
Sanders RW; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.; Weill Medical College, Cornell University, New York, USA.
van Gils MJ; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.
de Bruin S; Department of Intensive Care Medicine, Amsterdam UMC (Location AMC), University of Amsterdam, Amsterdam, Netherlands.
Vlaar APJ; Department of Intensive Care Medicine, Amsterdam UMC (Location AMC), University of Amsterdam, Amsterdam, Netherlands.
Rispens T; Department of Immunopathology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
den Dunnen J; Department of Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Zaaijer HL; Department of Blood-borne Infections, Sanquin, Amsterdam, Netherlands.
Wuhrer M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
Ellen van der Schoot C; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Vidarsson G; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands. .; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Pokaż więcej
Corporate Authors:
Amsterdam UMC COVID-19
biobank study group
Źródło:
Science (New York, N.Y.) [Science] 2021 Feb 26; Vol. 371 (6532). Date of Electronic Publication: 2020 Dec 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Viral/*immunology
COVID-19/*immunology
Immunoglobulin G/*immunology
SARS-CoV-2/*immunology
Adult ; Aged ; Antibodies, Viral/blood ; Antibodies, Viral/chemistry ; COVID-19/physiopathology ; Cells, Cultured ; Critical Illness ; Cytomegalovirus/immunology ; Female ; Fucose/analysis ; Glycosylation ; HIV/immunology ; Hepatitis B Vaccines/immunology ; Humans ; Immunoglobulin Fc Fragments/chemistry ; Immunoglobulin Fc Fragments/immunology ; Immunoglobulin G/blood ; Immunoglobulin G/chemistry ; Inflammation ; Interleukin-6/biosynthesis ; Interleukin-6/immunology ; Macrophages/immunology ; Male ; Middle Aged ; Parvovirus B19, Human/immunology ; Severity of Illness Index ; Spike Glycoprotein, Coronavirus/immunology ; Vaccines, Subunit/immunology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection.
Autorzy:
Connell BJ; Department of Medical Microbiology, Virology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Hermans LE; Department of Medical Microbiology, Virology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Ndlovu Research Consortium, Elandsdoorn, Limpopo Province, South Africa.
Wensing AMJ; Department of Medical Microbiology, Virology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Ndlovu Research Consortium, Elandsdoorn, Limpopo Province, South Africa.
Schellens I; Center for Translational Immunology, UMCU, Utrecht, The Netherlands.
Schipper PJ; Department of Medical Microbiology, Virology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
van Ham PM; Department of Medical Microbiology, Virology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
de Jong DTCM; Department of Medical Microbiology, Virology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Otto S; Center for Translational Immunology, UMCU, Utrecht, The Netherlands.
Mathe T; Ndlovu Research Consortium, Elandsdoorn, Limpopo Province, South Africa.
Moraba R; Ndlovu Research Consortium, Elandsdoorn, Limpopo Province, South Africa.
Borghans JAM; Center for Translational Immunology, UMCU, Utrecht, The Netherlands.
Papathanasopoulos MA; HIV Pathogenesis Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Kruize Z; Amsterdam University Medical Center, Amsterdam Infection and Immunity Institute, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Venter FWD; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Kootstra NA; Amsterdam University Medical Center, Amsterdam Infection and Immunity Institute, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Tempelman H; Ndlovu Research Consortium, Elandsdoorn, Limpopo Province, South Africa.
Tesselaar K; Center for Translational Immunology, UMCU, Utrecht, The Netherlands.
Nijhuis M; Department of Medical Microbiology, Virology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. .; Ndlovu Research Consortium, Elandsdoorn, Limpopo Province, South Africa. .; HIV Pathogenesis Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Sep 28; Vol. 10 (1), pp. 15866. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Viral Tropism*
HIV Infections/*immunology
HIV Infections/*metabolism
HIV-1/*physiology
Receptors, CCR5/*metabolism
Receptors, CXCR4/*metabolism
Adult ; Cross-Sectional Studies ; Female ; Humans ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.
Autorzy:
Brouwer PJM; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Caniels TG; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
van der Straten K; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.; Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Snitselaar JL; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Aldon Y; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bangaru S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Okba NMA; Department of Viroscience, Erasmus Medical Center, Rotterdam, 3015GD, Netherlands.
Claireaux M; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Kerster G; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bentlage AEH; Sanquin Research, Department of Experimental Immunohematology, Amsterdam, Netherlands and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1006AD Amsterdam, Netherlands.
van Haaren MM; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Guerra D; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Burger JA; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Schermer EE; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Verheul KD; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
van der Velde N; IBIS Technologies BV, 7521PR Enschede, Netherlands.
van der Kooi A; IBIS Technologies BV, 7521PR Enschede, Netherlands.
van Schooten J; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
van Breemen MJ; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bijl TPL; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Sliepen K; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Aartse A; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.; Department of Virology, Biomedical Primate Research Centre, 2288GJ Rijswijk, Netherlands.
Derking R; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Bontjer I; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Kootstra NA; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Wiersinga WJ; Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.
Vidarsson G; Sanquin Research, Department of Experimental Immunohematology, Amsterdam, Netherlands and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1006AD Amsterdam, Netherlands.
Haagmans BL; Department of Viroscience, Erasmus Medical Center, Rotterdam, 3015GD, Netherlands.
Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
de Bree GJ; Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands. .
Sanders RW; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands. .; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA.
van Gils MJ; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands. .
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2020 Aug 07; Vol. 369 (6504), pp. 643-650. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal/*immunology
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
Betacoronavirus/*immunology
Coronavirus Infections/*immunology
Pneumonia, Viral/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Adult ; Aged ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Antibody Affinity ; Antigens, Viral/immunology ; B-Lymphocyte Subsets/immunology ; Broadly Neutralizing Antibodies/immunology ; COVID-19 ; Cell Line, Tumor ; Coronavirus Infections/prevention & control ; Coronavirus Infections/therapy ; Epitopes/immunology ; Female ; Humans ; Immunologic Memory ; Immunophenotyping ; Male ; Middle Aged ; Pandemics/prevention & control ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/therapy ; Protein Domains ; Protein Interaction Domains and Motifs/immunology ; Receptors, Coronavirus ; Receptors, Virus/metabolism ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
MAVS Genetic Variation Is Associated with Decreased HIV-1 Replication In Vitro and Reduced CD4 T Cell Infection in HIV-1-Infected Individuals.
Autorzy:
Stunnenberg M; Amsterdam Infection & Immunity Institute, Department of Experimental Immunology, University of Amsterdam, Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
van Pul L; Amsterdam Infection & Immunity Institute, Department of Experimental Immunology, University of Amsterdam, Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Sprokholt JK; Amsterdam Infection & Immunity Institute, Department of Experimental Immunology, University of Amsterdam, Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
van Dort KA; Amsterdam Infection & Immunity Institute, Department of Experimental Immunology, University of Amsterdam, Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Gringhuis SI; Amsterdam Infection & Immunity Institute, Department of Experimental Immunology, University of Amsterdam, Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Geijtenbeek TBH; Amsterdam Infection & Immunity Institute, Department of Experimental Immunology, University of Amsterdam, Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Kootstra NA; Amsterdam Infection & Immunity Institute, Department of Experimental Immunology, University of Amsterdam, Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Viruses [Viruses] 2020 Jul 16; Vol. 12 (7). Date of Electronic Publication: 2020 Jul 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adaptor Proteins, Signal Transducing/*genetics
CD4-Positive T-Lymphocytes/*virology
HIV Infections/*virology
HIV-1/*physiology
Virus Replication/*physiology
Adaptor Proteins, Signal Transducing/metabolism ; Cytokines/metabolism ; DNA, Viral/genetics ; Gene Expression Regulation, Viral ; Genetic Variation/genetics ; HIV Infections/immunology ; Humans ; Viral Load/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Human Immunodeficiency Virus-Negative Men Who Have Sex With Men Have an Altered T-Cell Phenotype and Bioenergy Metabolism.
Autorzy:
Kruize Z; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, the Netherlands.
Maurer I; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, the Netherlands.
van Dort KA; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, the Netherlands.
van den Elshout MAM; Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
Hoornenborg E; Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
Booiman T; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, the Netherlands.; Halix, Leiden, the Netherlands.
Prins M; Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, the Netherlands.; Department of Infectious Diseases, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, the Netherlands.
Kootstra NA; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Jul 05; Vol. 7 (8), pp. ofaa284. Date of Electronic Publication: 2020 Jul 05 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction.
Autorzy:
Hertoghs N; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Nijmeijer BM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
van Teijlingen NH; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Fenton-May AE; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Kaptein TM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
van Hamme JL; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Kappes JC; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America.
Kootstra NA; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Hahn BH; Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, PA, United States of America.
Borrow P; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Ribeiro CMS; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Geijtenbeek TBH; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Dec 19; Vol. 14 (12), pp. e0226651. Date of Electronic Publication: 2019 Dec 19 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Host-Pathogen Interactions*
HIV-1/*pathogenicity
Langerhans Cells/*virology
Antigens, CD/metabolism ; Cells, Cultured ; HEK293 Cells ; Humans ; Langerhans Cells/immunology ; Lectins, C-Type/metabolism ; Mannose-Binding Lectins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Elevated Lipoprotein(a) in Perinatally HIV-Infected Children Compared With Healthy Ethnicity-Matched Controls.
Autorzy:
Van den Hof M; Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam, the Netherlands.
Klein Haneveld MJ; Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam, the Netherlands.
Blokhuis C; Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam, the Netherlands.
Scherpbier HJ; Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam, the Netherlands.
Jansen HPG; Department of Experimental Vascular Medicine and Vascular Medicine, Amsterdam, the Netherlands.
Kootstra NA; Department of Experimental Immunology, Amsterdam University Medical Centers, location Academic Medical Center, Amsterdam, the Netherlands.
Dallinga-Thie GM; Department of Experimental Vascular Medicine and Vascular Medicine, Amsterdam, the Netherlands.
Van Deventer SJH; Department of Gastroenterology, Leiden University Medical Center, Leiden, the Netherlands.
Tsimikas S; Sulpizio Cardiovascular Center, Division of Cardiovascular Medicine, University California San Diego, La Jolla, California.
Pajkrt D; Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam, the Netherlands.
Pokaż więcej
Corporate Authors:
NOVICE study group
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2019 Sep 02; Vol. 6 (9), pp. ofz301. Date of Electronic Publication: 2019 Sep 02 (Print Publication: 2019).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Systemic and intrathecal immune activation in association with cerebral and cognitive outcomes in paediatric HIV.
Autorzy:
Blokhuis C; Department of Paediatric Haematology, Immunology and Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center (AMC), Emma Children's Hospital, Amsterdam, The Netherlands. .
Peeters CFW; Department of Epidemiology & Biostatistics, Amsterdam Public Health Research Institute, Amsterdam University Medical Centers, location VU University Medical Center (VUmc), Amsterdam, The Netherlands.
Cohen S; Department of Paediatric Haematology, Immunology and Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center (AMC), Emma Children's Hospital, Amsterdam, The Netherlands.
Scherpbier HJ; Department of Paediatric Haematology, Immunology and Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center (AMC), Emma Children's Hospital, Amsterdam, The Netherlands.
Kuijpers TW; Department of Paediatric Haematology, Immunology and Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center (AMC), Emma Children's Hospital, Amsterdam, The Netherlands.
Reiss P; Department of Global Health and Amsterdam Institute of Global Health and Development, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands.; HIV Monitoring Foundation, Amsterdam, The Netherlands.; Department of Internal Medicine, div. of Infectious Diseases, Amsterdam Institute of Infection and Immunity, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands.
Kootstra NA; Department of Experimental Immunology, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands.
Teunissen CE; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam University Medical Centers, location VUmc, Neurocampus, Amsterdam, The Netherlands.
Pajkrt D; Department of Paediatric Haematology, Immunology and Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center (AMC), Emma Children's Hospital, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 May 29; Vol. 9 (1), pp. 8004. Date of Electronic Publication: 2019 May 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cognitive Dysfunction/*immunology
HIV Infections/*immunology
Immunity, Cellular/*genetics
Inflammation/*immunology
Adolescent ; Biomarkers/blood ; Brain Injuries/complications ; Brain Injuries/immunology ; Brain Injuries/pathology ; Brain Injuries/virology ; Chemokine CCL2/genetics ; Chemokine CXCL10/genetics ; Child ; Cognitive Dysfunction/complications ; Cognitive Dysfunction/pathology ; Cognitive Dysfunction/virology ; Female ; HIV/pathogenicity ; HIV Infections/complications ; HIV Infections/pathology ; HIV Infections/virology ; Humans ; Inflammation/complications ; Inflammation/pathology ; Inflammation/virology ; Male ; Neuroimaging ; Pediatrics ; White Matter/immunology ; White Matter/pathology ; White Matter/virology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristics.
Autorzy:
De Francesco D; University College London, London, United Kingdom.
Wit FW; Academisch Medisch Centrum, Universiteit van Amsterdam, Amsterdam, The Netherlands.; Stichting HIV Monitoring, Amsterdam, The Netherlands.
Cole JH; Imperial College London, London, United Kingdom.
Kootstra NA; Academisch Medisch Centrum, Universiteit van Amsterdam, Amsterdam, The Netherlands.
Winston A; Imperial College London, London, United Kingdom.
Sabin CA; University College London, London, United Kingdom.
Underwood J; Imperial College London, London, United Kingdom.
van Zoest RA; Academisch Medisch Centrum, Universiteit van Amsterdam, Amsterdam, The Netherlands.
Schouten J; Academisch Medisch Centrum, Universiteit van Amsterdam, Amsterdam, The Netherlands.
Kooij KW; Academisch Medisch Centrum, Universiteit van Amsterdam, Amsterdam, The Netherlands.
Prins M; GGD Amsterdam, Public Health Service Amsterdam, Amsterdam, The Netherlands.
Guaraldi G; Università degli studi di Modena e Reggio Emilia, Modena, Italy.
Caan MWA; Academisch Medisch Centrum, Universiteit van Amsterdam, Amsterdam, The Netherlands.
Burger D; Stichting Katholieke Universiteit Nijmegen, Nijmegen, The Netherlands.
Franceschi C; Alma Mater Studiorum Universita di Bologna, Bologna, Italy.
Libert C; Vlaams Instituut voor Biotechnologie, Ghent, Belgium.
Bürkle A; Universität Konstanz, Konstanz, Germany.
Reiss P; Academisch Medisch Centrum, Universiteit van Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Corporate Authors:
COmorBidity in Relation to AIDS (COBRA) collaboration
Źródło:
PloS one [PLoS One] 2018 Mar 29; Vol. 13 (3), pp. e0191791. Date of Electronic Publication: 2018 Mar 29 (Print Publication: 2018).
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Acquired Immunodeficiency Syndrome/*epidemiology
Noncommunicable Diseases/*epidemiology
Acquired Immunodeficiency Syndrome/complications ; Acquired Immunodeficiency Syndrome/drug therapy ; Anti-HIV Agents/therapeutic use ; Comorbidity ; Female ; Follow-Up Studies ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Netherlands ; Socioeconomic Factors ; United Kingdom
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dynamics of the Immune Response in Acute Hepatitis B Infection.
Autorzy:
Stelma F; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Willemse SB; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Erken R; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
de Niet A; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Sinnige MJ; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
van Dort K; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Zaaijer HL; Department of Clinical Virology, Academic Medical Center, Amsterdam, the Netherlands.
van Leeuwen EMM; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Kootstra NA; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Reesink HW; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2017 Dec 20; Vol. 4 (4), pp. ofx231. Date of Electronic Publication: 2017 Dec 20 (Print Publication: 2017).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
NK cells in self-limited HCV infection exhibit a more extensively differentiated, but not memory-like, repertoire.
Autorzy:
de Groen RA; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Groothuismink ZMA; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
van Oord G; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Kootstra NA; Department of Research, Cluster of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Janssen HLA; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Liver Clinic University Health Network, Division of Gastroenterology, University of Toronto, Toronto, ON, Canada.
Prins M; Department of Research, Cluster of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Schinkel J; Section of Clinical Virology, Department of Medical Microbiology, Academic Medical Center, Amsterdam, The Netherlands.
Boonstra A; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2017 Nov; Vol. 24 (11), pp. 917-926. Date of Electronic Publication: 2017 May 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell Differentiation*/immunology
Immunologic Memory*
Hepacivirus/*immunology
Hepatitis C/*immunology
Hepatitis C/*virology
Killer Cells, Natural/*cytology
Killer Cells, Natural/*immunology
Adult ; Biomarkers ; CD56 Antigen/metabolism ; Cohort Studies ; Cytokines/metabolism ; Female ; Genotype ; Granzymes/metabolism ; Hepatitis C/metabolism ; Humans ; Immunophenotyping ; Killer Cells, Natural/metabolism ; Lymphocyte Count ; Male ; Middle Aged ; Receptors, Natural Cytotoxicity Triggering/metabolism ; TNF-Related Apoptosis-Inducing Ligand/metabolism ; Viral Load ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls.
Autorzy:
Booiman T; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
Wit FW; Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.; Department of Global Health & Division of Infectious Disease, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; HIV Monitoring Foundation, Amsterdam, The Netherlands.
Girigorie AF; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
Maurer I; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
De Francesco D; Department of Infection and Population Health, University College London, London, United Kingdom.
Sabin CA; Department of Infection and Population Health, University College London, London, United Kingdom.
Harskamp AM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Prins M; Public health service, Amsterdam, The Netherlands.
Franceschi C; Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum Universita di Bologna, Bologna, Italy.
Deeks SG; Department of Medicine, University of California, San Francisco, California, United States of America.
Winston A; Imperial College of Science, Technology and Medicine, London, United Kingdom.
Reiss P; Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.; Department of Global Health & Division of Infectious Disease, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; HIV Monitoring Foundation, Amsterdam, The Netherlands.
Kootstra NA; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Corporate Authors:
Co-morBidity in Relation to Aids (COBRA) Collaboration
Źródło:
PloS one [PLoS One] 2017 Aug 14; Vol. 12 (8), pp. e0183357. Date of Electronic Publication: 2017 Aug 14 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Antiretroviral Therapy, Highly Active*
Cell Differentiation*
Life Style*
CD4-Positive T-Lymphocytes/*immunology
CD8-Positive T-Lymphocytes/*immunology
Cytomegalovirus Infections/*immunology
HIV Seropositivity/*drug therapy
HIV Seropositivity/*immunology
Adult ; Aged ; Blood Donors ; Case-Control Studies ; Cytomegalovirus/physiology ; Cytomegalovirus Infections/virology ; HIV Seropositivity/virology ; HIV-1/physiology ; Humans ; Lymphocyte Activation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid.
Autorzy:
Booiman T; Department of Experimental Immunology and.; Amsterdam Institute for Global Health and Development, Netherlands.
Wit FW; Department of Global Health and Division of Infectious Disease, Academic Medical Center, University of Amsterdam, Netherlands.; Amsterdam Institute for Global Health and Development, Netherlands.
Maurer I; Department of Experimental Immunology and.
De Francesco D; Department of Infection and Population Health, University College London, United Kingdom.
Sabin CA; Department of Infection and Population Health, University College London, United Kingdom.
Harskamp AM; Department of Experimental Immunology and.
Prins M; Public Health Service, Amsterdam, Netherlands.
Garagnani P; Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum Universita di Bologna, Italy.
Pirazzini C; Istituto di Ricovero e Cura a Carattere Scientifico, Institute of Neurological Sciences of Bologna, Bellaria Hospital, Italy.
Franceschi C; Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum Universita di Bologna, Italy.
Fuchs D; Division of Biological Chemistry, Biocenter Innsbruck Medical University Center for Chemistry and Biomedicine, Austria.
Gisslén M; Institute of Biomedicine, Department of Infectious Diseases, the Sahlgrenska Academy at the University of Gothenburg, Sweden.
Winston A; Imperial College of Science, Technology and Medicine, London, United Kingdom.
Reiss P; Department of Global Health and Division of Infectious Disease, Academic Medical Center, University of Amsterdam, Netherlands.; Amsterdam Institute for Global Health and Development, Netherlands.; HIV Monitoring Foundation, Amsterdam, Netherlands; and.
Kootstra NA; Department of Experimental Immunology and.
Pokaż więcej
Corporate Authors:
Comorbidity in Relation to AIDS (COBRA) Collaboration
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2017 May 25; Vol. 4 (3), pp. ofx108. Date of Electronic Publication: 2017 May 25 (Print Publication: 2017).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Hepatitis B Virus Protein X Induces Degradation of Talin-1.
Autorzy:
van de Klundert MA; Department of Blood-borne Infections, Sanquin Research, 1006 AD Amsterdam, The Netherlands.; Department of Experimental Immunology, Landsteiner Laboratory, and Center for Infectious Diseases and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
van den Biggelaar M; Department of Plasma Proteins, Sanquin Research, 1006 AD Amsterdam, The Netherlands. .
Kootstra NA; Department of Experimental Immunology, Landsteiner Laboratory, and Center for Infectious Diseases and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. n.a.kootstra@amc.uva.nl.
Zaaijer HL; Department of Blood-borne Infections, Sanquin Research, 1006 AD Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Viruses [Viruses] 2016 Oct 19; Vol. 8 (10). Date of Electronic Publication: 2016 Oct 19.
Typ publikacji:
Journal Article
MeSH Terms:
Host-Pathogen Interactions*
Proteolysis*
Hepatitis B virus/*physiology
Talin/*metabolism
Trans-Activators/*metabolism
Cell Line ; Humans ; Viral Regulatory and Accessory Proteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
HLA-C and KIR combined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy.
Autorzy:
Stelma F; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Jansen L; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Sinnige MJ; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
van Dort KA; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Takkenberg RB; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.
Janssen HL; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.; Toronto Centre for Liver Disease, Toronto Western & General Hospital, University Health Network, Toronto, Canada.
Reesink HW; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Kootstra NA; Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2016 Aug; Vol. 23 (8), pp. 652-9. Date of Electronic Publication: 2016 Mar 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*therapeutic use
HLA-C Antigens/*genetics
Hepatitis B e Antigens/*blood
Hepatitis B, Chronic/*drug therapy
Hepatitis B, Chronic/*genetics
Interferons/*therapeutic use
Receptors, KIR2DL1/*genetics
Adult ; Biomarkers/analysis ; Drug Therapy, Combination/methods ; Female ; Hepatitis B, Chronic/diagnosis ; Humans ; Male ; Middle Aged ; Prognosis ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds.
Autorzy:
van den Kerkhof TL; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
de Taeye SW; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
Boeser-Nunnink BD; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
Burton DR; Department of Immunology and Microbial Science and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.
Kootstra NA; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
Schuitemaker H; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.; Janssen Pharmaceuticals, 2333 CN, Leiden, The Netherlands.
Sanders RW; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands. .; Department of Microbiology and Immunology, Weill Medical College, Cornell University, New York, NY, 10065, USA. .
van Gils MJ; Department of Microbiology and Immunology, Weill Medical College, Cornell University, New York, NY, 10065, USA. .
Pokaż więcej
Źródło:
Retrovirology [Retrovirology] 2016 Jul 07; Vol. 13 (1), pp. 48. Date of Electronic Publication: 2016 Jul 07.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Immune Evasion*
Antibodies, Neutralizing/*immunology
HIV Antibodies/*immunology
HIV-1/*immunology
HIV-1/*metabolism
env Gene Products, Human Immunodeficiency Virus/*chemistry
env Gene Products, Human Immunodeficiency Virus/*immunology
Cysteine ; Disulfides ; HIV-1/chemistry ; HIV-1/genetics ; Humans ; Male ; Polysaccharides/chemistry ; Polysaccharides/immunology ; env Gene Products, Human Immunodeficiency Virus/genetics ; env Gene Products, Human Immunodeficiency Virus/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Identification of FDA-approved drugs that target hepatitis B virus transcription.
Autorzy:
van de Klundert MA; Department of Blood-borne Infections, Sanquin Research, Amsterdam, The Netherlands.; Department of Experimental Immunology, Landsteiner Laboratory, and Center for Infectious Diseases and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Zaaijer HL; Department of Blood-borne Infections, Sanquin Research, Amsterdam, The Netherlands.
Kootstra NA; Department of Experimental Immunology, Landsteiner Laboratory, and Center for Infectious Diseases and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2016 Mar; Vol. 23 (3), pp. 191-201. Date of Electronic Publication: 2015 Oct 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Repositioning*
Antiviral Agents/*isolation & purification
Antiviral Agents/*pharmacology
Hepatitis B virus/*drug effects
Transcription, Genetic/*drug effects
Cell Line ; Drug Evaluation, Preclinical/methods ; Humans ; Microbial Sensitivity Tests ; Virus Replication/drug effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 42

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies